The PREP Act provides immunity to various stakeholders involved in the development, manufacturing, distribution, and administration of covered countermeasures. This includes pharmaceutical companies, healthcare providers, and even government agencies. The immunity is designed to encourage the rapid development and deployment of medical countermeasures without the fear of legal repercussions.
